XDx Registers for IPO

Brisbane, Calif.-based biotech firm XDx Inc. on Wednesday announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.

XDx specializes in molecular diagnostics for the monitoring of transplant rejection and autoimmune diseases.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Second grader Genesis Ulloa leads students in an after-school community hub in a game at the Mission YMCA on Friday, May 7, 2021. (Kevin N. Hume/S.F. Examiner)
SF parents face school year with hope, trepidation and concern

‘Honestly, I don’t know how I’m going to deal with it’

Health care workers in the intensive care unit at Providence Saint John’s Health Center in Santa Monica, with Alejandro Balderas, a 44-year-old patient who later died. Even in California, a state with a coronavirus vaccination rate well above average, the number of people hospitalized with COVID-19 has nearly doubled in the past two weeks, according to a New York Times database. (Isadora Kosofsky/The New York Times)
Why COVID took off in California, again

‘The good news is: The vaccines are working’

Lake Oroville stood at 33 percent full and 40 percent of historical average when this photograph was taken on Tuesday, June 29, 2021. (Brian van der Brug / Los Angeles Times via Tribune News Service)
A kayaker on the water at Lake Oroville, which stands at 33 percent full and 40 percent of historical average when this photograph was taken on Tuesday, June 29, 2021 in Oroville, Calif. (Brian van der Brug / Los Angeles Times via Tribune News Service)
Facing ‘dire water shortages,’ California bans Delta pumping

By Rachel Becker CalMatters In an aggressive move to address “immediate and… Continue reading

Most Read